J&J Unit Secures Duty-Free Treatment For HIV Drug
The U.S. Court of International Trade ruled Thursday that the HIV drug Prezista should enter the U.S. duty-free, handing victory to a Johnson & Johnson subsidiary that claims to have paid...To view the full article, register now.
Already a subscriber? Click here to view full article